Skip to content

    Recently Viewed

      Listening...

      Home / Latest news / Our heritage /
      Meet Dr. Paul Janssen: a legend in pharmacology
      Dr. Paul Janssen, a Belgian Physician and Founder of Janssen

      Meet Dr. Paul Janssen: a legend in pharmacology

      When Janssen Pharmaceuticals merged with Johnson & Johnson in the early 1960s, a fruitful collaboration that continues to this day was born. Learn about the man who coined over 100 patents and developed dozens of life-changing medications.

      Share Article
      share to

      Putting people first is at the heart of Johnson & Johnson’s company Credo. And that wouldn’t be possible if not for the remarkable people who have trailblazed at the company since its founding in 1886.

      In the latest installment of our “Employee Blast from the Past” series, we’re putting the spotlight on Paul Janssen, without whom the Janssen Pharmaceutical Companies of Johnson & Johnson—and the groundbreaking work that comes out of their labs—wouldn’t exist.The Employee ...
      Paul Janssen, Namesake, the Janssen Pharmaceutical Companies of Johnson & Johnson, 1961-1991

      Why he’s so legendary ...
      Janssen, the son of a doctor, was born in Belgium in 1926. And although his father’s vocation no doubt inspired his own passion for medicine, he was driven toward research after the loss of his 4-year-old sister to tuberculous meningitis. Despite modest financial means, he boldly founded his own independent research lab at the age of 27.

      Early on, Janssen recognized the relationship between a compound’s chemical structure and its action as a medicine and, in turn, synthesized many revolutionary drug compounds, including a breakthrough treatment for psychotic disorders. To further grow his lab’s potential, Janssen decided to merge his company with Johnson & Johnson, a move that was finalized in February 1962.

      The rest, as they say, is history.

      Dr. Paul Janssen and Koen Andres

      Janssen with scientist Koen Andries, who later discovered a new drug to treat tuberculosis

      Johnson & Johnson’s resources dovetailed perfectly with the pace of Janssen’s research enterprise, which at the time of Janssen’s passing in 2003, had grown to 34 foreign affiliates and a workforce of 16,000—and an impressive portfolio of noteworthy medications, including Imodium®, a potentially lifesaving treatment for diarrhea.

      As Janssen made the rounds of his research labs, he was known for relentlessly asking: “What’s new?” So it’s only fitting that, after his death, the company made his dream discovery: the first new treatment for tuberculosis in more than 40 years.

      What most people don’t know ...
      After setting up the first western pharmaceutical company in China, Janssen became involved in the fate of one of their national treasures: the historic Xian Terracotta Army, whose façades were being destroyed by mold.

      Janssen helped protect and preserve the statues by using antifungal medicine from his lab—and the Janssen Pharmaceutical Companies of Johnson & Johnson continues to aid in the preservation of these priceless artifacts.

      When you’ve been innovating for over 135 years …

      Johnson & Johnson has a virtual museum where you can learn more fun facts about its rich history.

      More from Johnson & Johnson

      Health & wellness
       Intense and extreme heat wave under the sun illustrating the impact of climate change

      Building climate-resilient health clinics

      When Mother Nature strikes—think triple-digit heatwaves, wildfires, hurricanes—vulnerable populations are at risk of missing out on much-needed healthcare. For Earth Day, learn how Johnson & Johnson is helping community clinics protect patients.
      Latest news
      Q1 2024-1x1.png

      What you need to know about Johnson & Johnson’s 2024 first-quarter earnings

      Here’s an infographic breakdown of the company’s first-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
      Latest news
      healthcare worker in protective medical gear

      Johnson & Johnson named to Fortune’s 2024 America’s Most Innovative Companies list

      The company’s drive to develop novel solutions for the world’s toughest healthcare challenges has earned it a spot on Fortune’s second annual list.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.